Attached files

file filename
10-Q/A - MARIZYME INCv223683_10qa.htm
EX-31.2 - MARIZYME INCv223683_ex31-2.htm
EX-10.7 - MARIZYME INCv223683_ex10-7.htm
EX-31.1 - MARIZYME INCv223683_ex31-1.htm
EX-10.8 - MARIZYME INCv223683_ex10-8.htm
EX-10.9 - MARIZYME INCv223683_ex10-9.htm
EX-32.1 - MARIZYME INCv223683_ex32-1.htm
EX-10.1 - MARIZYME INCv223683_ex10-1.htm
EX-10.3 - MARIZYME INCv223683_ex10-3.htm
EX-10.5 - MARIZYME INCv223683_ex10-5.htm
EX-10.6 - MARIZYME INCv223683_ex10-6.htm
EX-10.4 - MARIZYME INCv223683_ex10-4.htm
EX-10.2 - MARIZYME INCv223683_ex10-2.htm
 
Exhibit 32.2
 
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
 
I, Ronald Everett, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
 
 
(1)
the quarterly report on Form 10-Q Amendment No. 2 of GBS Enterprises Incorporated for the fiscal quarter ended December 31, 2010 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
     
 
(2)
the information contained in the Form 10-Q Amendment No. 2 fairly presents, in all material respects, the financial condition and results of operations of GBS Enterprises Incorporated.
 
 Date: May 20, 2011
/s/ Ronald Everett
 
Ronald Everett
 
Chief Financial Officer
 
(Principal Financial and Accounting Officer)